Connecticut Delegation Urged to Secure $50 Million for ME/CFS Research
Connecticut's congressional delegation is urged to secure $50 million in federal funding for the NIH ME/CFS Research Roadmap, aiming to address Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a disease affecting thousands in the state and nation that lacks approved treatments and…
Hartford & New Haven, CT, August 31, 2026 —
Efforts are underway to encourage Connecticut’s congressional delegation to champion a significant federal funding initiative for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) research. The specific goal is to secure $50 million in federal funding dedicated to the National Institutes of Health (NIH) ME/CFS Research Roadmap.
This funding is sought to advance understanding and develop solutions for ME/CFS, a complex and often debilitating condition. The disease impacts thousands of individuals across Connecticut and the nation. However, ME/CFS currently presents a significant challenge due to a lack of approved treatments and validated diagnostic tests.
The call for securing this federal investment highlights the urgent need for scientific progress in addressing ME/CFS. The NIH ME/CFS Research Roadmap represents a structured approach to accelerate research in key areas, potentially leading to breakthroughs in diagnosis and therapeutics.
Specific details regarding which entities or individuals are urging the delegation, or the exact timeline for these requests, were not provided. Similarly, the specific components or objectives of the NIH ME/CFS Research Roadmap beyond its general aim to advance research were not detailed in the provided information. The precise number of individuals affected by ME/CFS in Connecticut or nationally was also not specified, beyond noting that it affects
Story summarized from the original created by Subramani Seetharama on ctmirror.org, see more information here.
Media gallery
